Country

bionomics-and-ctx-reach-proof-of-concept-milestone-in-the-discovery-and-preclinical-evaluation-of-ctx-0357927-which-suppresses-cancer-progression

Bionomics, CTx advance in growth factor research

  • Australia
  • |
  • News

Singapore: Bionomics joint program with the Australian Partner consortium Co-operative Research Centre for Cancer Therapeutics (CTx) has reached a proof of concept milestone in the discovery and preclinical evaluation of inhibitors of vascular... Read more

actavis-new-drug-application-nda-for-progestin-only-transdermal-contraceptive-patch-norethindrone-transdermal-delivery-system-gets-fda-nod

Actavis 'pregnancy preventer' gets FDA nod


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone... Read more

awak-technologies-bags-singapore-innovation-enterprise-award

Awak wins NUS award for 'wearable' artificial kidney...


  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Singapore-based Awak Technologies has bagged Promising NUS Start-up Award at Innovation & Enterprise (I&E) Awards... Read more

pharmabcine-uses-avacta-analytical-optim-1000-microvolume-protein-analysis-instrument-to-complete-formulation-and-stability-studies

PharmAbcine uses Avacta instrument for R&D

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Scientists at Korean biotech company PharmAbcine are completing formulation and stability studies based on Optim 1000 microvolume... Read more

patrys-cancer-drug-gives-hope-to-patients

Patrys cancer drug gives hope to patients

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has demonstrated the... Read more

chinese-and-hong-kong-researchers-develop-map-of-avian-influenza-h7n9-comprising-of-bird-migration-patterns-and-estimations-of-poultry-production-and-consumption

Chinese, Hong Kong scientists map H7N9 risk infection

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production and consumption,... Read more

the-debate-still-continues-where-is-india-lacking-on-the-regulatory-front

What can India do to streamline its regulatory processes?

  • India
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

India's growing ability to innovate and provide efficient and cost-effective solutions to various bioscience problems plaguing the nation... Read more

dr-smita-singhania-consultant-getz-pharma-india-and-natco-pharma-india-and-director-symbiosis-school-of-biomedical-sciences-symbiosis-international-university-pune-india

Smita Singhania: Avoid 'made-in-India' bias in quality approvals

  • India
  • |
  • Opinion
  • |
  • By Rahul Koul
  • |
  • 0 Comment

The Central Drugs Standard Control Organization and Department of Biotechnology mutually formed and implemented the national regulatory... Read more

the-acquisition-combines-inviragen-s-expertise-in-viral-vaccine-r-d-and-takeda-s-resources-product-development-expertise-and-global-reach

Novartis: Lucentis reduces AMD blindness by 50%

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Novartis revealed new clinical data associated with the eye drug Lucentis (ranibizumab) admist a total of 209 abstracts from... Read more

the-acquisition-combines-inviragen-s-expertise-in-viral-vaccine-r-d-and-takeda-s-resources-product-development-expertise-and-global-reach

Takeda to acquire Inviragen for $250 mn

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japanese company, Takeda Pharmaceutical is looking to acquire Inviragen for an upfront payment of $35 million, and future payments... Read more

concert-pharma-and-celgene-s-strategic-collaboration-is-directed-towards-deuterium-modified-compounds-targeting-cancer-and-inflammation

Concert Pharma, Celgene enter in $300 mn merger

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Concert Pharmaceuticals entered into a strategic collaboration with Celgene Corporation directed towards deuterium-modified compounds... Read more

aeras-oxford-university-okairos-get-usd2

Bill Gates pays $2.9mn for TB, malaria, HIV vaccine

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Aeras, a nonprofit biotech firm that is advancing TB vaccines, the University of Oxford and Okairos, a biopharmaceutical company... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X